Cancers, Vol. 11, Pages 1231: Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance

Cancers, Vol. 11, Pages 1231: Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance Cancers doi: 10.3390/cancers11091231 Authors: Weihua Zhou Daniel R. Wahl Glioblastoma (GBM) is the most common and aggressive primary brain tumor and is nearly universally fatal. Targeted therapy and immunotherapy have had limited success in GBM, leaving surgery, alkylating chemotherapy and ionizing radiation as the standards of care. Like most cancers, GBMs rewire metabolism to fuel survival, proliferation, and invasion. Emerging evidence suggests that this metabolic reprogramming also mediates resistance to the standard-of-care therapies used to treat GBM. In this review, we discuss the noteworthy metabolic features of GBM, the key pathways that reshape tumor metabolism, and how inhibiting abnormal metabolism may be able to overcome the inherent resistance of GBM to radiation and chemotherapy.
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research